Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 42%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings Inc is exhibiting strong financial performance, highlighted by a gross margin of 71.1%, which represents a year-over-year increase of 230 basis points and exceeds consensus expectations. The company has projected revenue for 2025 to be between $870 million to $880 million, indicating a year-over-year growth rate of 16%-18%, alongside a consistent trend of over 20% year-over-year revenue growth for five consecutive quarters. Additionally, anticipated improvements in EBITDA margins and contributions from pricing and mix enhancements further bolster the company's positive outlook.

Bears say

iRhythm Holdings Inc faces a challenging outlook primarily due to anticipated growth slowing to the low-teens, coupled with expectations of flat pricing in 2026, which could limit revenue expansion. The company is also susceptible to multiple risks, including adverse changes in commercial reimbursement practices, heightened competition in the cardiac monitoring market, and the potential failure of key product launches like ZioAT to generate anticipated market traction. Furthermore, the presence of substantial operating expenses combined with risks related to sales execution and the possibility of additional equity offerings adds to the overall financial uncertainty surrounding the company.

iRhythm Technologies (IRTC) has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 42% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 12 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $208.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $208.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.